Diaphorina citri psyllid: psy10113


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590------
MSNNTPLKKVPIHLQSSQNRLLIKNGKVVNADKISDLDIYIENGVIQQLGRNLIVPGGVRVIDAAGSYVIPGGIDPHTHFELELMGATSVDDFYHGTKAAVAGGTTTIIDFALPRKGESLIKTYESWRQKADEKVCCDYALHVGITWWSDQVQQEMAELCEKHGVNSFKTFMAYKGLYMLSDGELYDAFSAIKNLGAIAMVHAENGEIIDKNTQKLLAAGIKGPEGHQLSRPEEVEAEAVTRACTIANQVDCPLYVVHIMSKAAGDAMAYKRKELMKKGKHCTLYGETLAAAVGTHANQIPCTWHDQAAHVLSPPLRPDETTPTHLLTLLNENALQTTGSDNCTFNKNQKELGKDSFTHIPNGVNGVQDRLSVIWEKGVVPGILSPEKFVAVTSTNAAKIFNLYPKKGVIAEGSDADIVVWNYKAKRTISAKTHAHACDYNIFEGLVCHGVPEYVIVGGRVCVDEGNLRVAQGQGNYLPTHTNPPFVYEGQTPEVDIDHKENHEVIEEIREKLHGLTPNNNHKISAPRSPSYSSTSSVYGDADYGHNQIHTGKGMRPEGQRDLQSSSMSVCGEIEDAGHRSSIRVRNPPGGKSSGF
ccccccccccccccccccccEEEEccEEEcccccEEEEEEEEccEEEEEccccccccccEEEEccccccccccccccccccccccccccccccHHHHHHHHHcccEEEEccccccccccHHHHHHHHHHHHccccEEEcccccEEEcccHHHHHHHHHHHHHccccEEEEEEEccccccccHHHHHHHHHHHHHcccEEEEEcccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHcccEEEEEcccHHHHHHHHHHHHHHHHccccccEEEEccccEECccccccccccccccccCCccccccccccHHHHHHHHcccccCEEEcccccccHHHHHcccccccccccccccHHHHHHHHHHHHcccccccHHHHHHHHcHHHHHHcccccccccccccccccEEEEEcccEEEEccccccccccccccccCEEEEEEEEEEEccEEEEEccEEEECccccCECccccccccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
**************QSSQNRLLIKNGKVVNADKISDLDIYIENGVIQQLGRNLIVPGGVRVIDAAGSYVIPGGIDPHTHFELELMGATSVDDFYHGTKAAVAGGTTTIIDFALPRKGESLIKTYESWRQKADEKVCCDYALHVGITWWSDQVQQEMAELCEKHGVNSFKTFMAYKGLYMLSDGELYDAFSAIKNLGAIAMVHAENGEIIDKNTQKLLAAGIKGPEGHQLSRPEEVEAEAVTRACTIANQVDCPLYVVHIMSKAAGDAMAYKRKELMKKGKHCTLYGETLAAAVGTHANQIPCTWHDQAAHVLSPPLRPDETTPTHLLTLLNENALQTTGSDNCTFNKNQKELGKDSFTHIPNGVNGVQDRLSVIWEKGVVPGILSPEKFVAVTSTNAAKIFNLYPKKGVIAEGSDADIVVWNYKAKRTISAKTHAHACDYNIFEGLVCHGVPEYVIVGGRVCVDEGNLRVAQGQGNYLPTHTNPPFVYEGQT****************************************************************************S***E******RSSIRVRN**G******
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSNNTPLKKVPIHLQSSQNRLLIKNGKVVNADKISDLDIYIENGVIQQLGRNLIVPGGVRVIDAAGSYVIPGGIDPHTHFELELMGATSVDDFYHGTKAAVAGGTTTIIDFALPRKGESLIKTYESWRQKADEKVCCDYALHVGITWWSDQVQQEMAELCEKHGVNSFKTFMAYKGLYMLSDGELYDAFSAIKNLGAIAMVHAENGEIIDKNTQKLLAAGIKGPEGHQLSRPEEVEAEAVTRACTIANQVDCPLYVVHIMSKAAGDAMAYKRKELMKKGKHCTLYGETLAAAVGTHANQIPCTWHDQAAHVLSPPLRPDETTPTHLLTLLNENALQTTGSDNCTFNKNQKELGKDSFTHIPNGVNGVQDRLSVIWEKGVVPGILSPEKFVAVTSTNAAKIFNLYPKKGVIAEGSDADIVVWNYKAKRTISAKTHAHACDYNIFEGLVCHGVPEYVIVGGRVCVDEGNLRVAQGQGNYLPTHTNPPFVYEGQTPEVDIDHKENHEVIEEIREKLHGLTPNNNHKISAPRSPSYSSTSSVYGDADYGHNQIHTGKGMRPEGQRDLQSSSMSVCGEIEDAGHRSSIRVRNPPGGKSSGF

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Dihydropyrimidinase 2 confidentQ18677
Dihydropyrimidinase Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.confidentQ63150
Dihydropyrimidinase Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.confidentQ9EQF5

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0044763 [BP]single-organism cellular processconfidentGO:0009987, GO:0008150, GO:0044699
GO:0043234 [CC]protein complexconfidentGO:0005575, GO:0032991
GO:0043231 [CC]intracellular membrane-bounded organelleconfidentGO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0005829 [CC]cytosolconfidentGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0006206 [BP]pyrimidine nucleobase metabolic processconfidentGO:0006139, GO:0044710, GO:0044238, GO:1901564, GO:0071704, GO:0009987, GO:0006725, GO:0044237, GO:0009112, GO:0034641, GO:0006807, GO:0008150, GO:1901360, GO:0008152, GO:0072527, GO:0044281, GO:0055086, GO:0046483
GO:0050794 [BP]regulation of cellular processconfidentGO:0008150, GO:0065007, GO:0050789
GO:0044707 [BP]single-multicellular organism processconfidentGO:0032501, GO:0008150, GO:0044699
GO:0043167 [MF]ion bindingconfidentGO:0003674, GO:0005488
GO:0043005 [CC]neuron projectionconfidentGO:0005575, GO:0097458, GO:0042995, GO:0044464, GO:0005623
GO:0016043 [BP]cellular component organizationconfidentGO:0008150, GO:0071840
GO:0051491 [BP]positive regulation of filopodium assemblyprobableGO:0051130, GO:0051489, GO:0051128, GO:0050789, GO:0044087, GO:0060491, GO:0065007, GO:0048518, GO:0008150, GO:0031346, GO:0031344, GO:0050794, GO:0048522
GO:0002059 [MF]thymine bindingprobableGO:0097159, GO:0036094, GO:0003674, GO:0005488, GO:0002054, GO:0002061, GO:1901363
GO:0051017 [BP]actin filament bundle assemblyprobableGO:0006996, GO:0007015, GO:0044699, GO:0022607, GO:0007010, GO:0030029, GO:0071822, GO:0043933, GO:0009987, GO:0030036, GO:0044085, GO:0044763, GO:0016043, GO:0008150, GO:0071840
GO:0017124 [MF]SH3 domain bindingprobableGO:0003674, GO:0019904, GO:0005515, GO:0005488
GO:0005615 [CC]extracellular spaceprobableGO:0005575, GO:0005576, GO:0044421
GO:0007613 [BP]memoryprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0050890, GO:0007610, GO:0007611, GO:0008150, GO:0050877, GO:0044699, GO:0003008
GO:0006207 [BP]'de novo' pyrimidine nucleobase biosynthetic processprobableGO:0072528, GO:0044249, GO:0034641, GO:0006807, GO:0044281, GO:0046112, GO:1901362, GO:1901360, GO:0072527, GO:1901576, GO:0044710, GO:0019856, GO:0006206, GO:0071704, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009112, GO:0009058, GO:0008150, GO:0008152, GO:1901564, GO:0055086, GO:0046483, GO:0044238, GO:0044271, GO:1901566, GO:0044237
GO:0031941 [CC]filamentous actinprobableGO:0043234, GO:0005856, GO:0032991, GO:0015629, GO:0043232, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0043229, GO:0044430, GO:0005884, GO:0005575, GO:0044424, GO:0043228, GO:0043226, GO:0044422
GO:0030027 [CC]lamellipodiumprobableGO:0005575, GO:0042995, GO:0044464, GO:0031252, GO:0005623
GO:0043195 [CC]terminal boutonprobableGO:0044306, GO:0043679, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0044456, GO:0045202, GO:0043005, GO:0033267, GO:0042995
GO:0035374 [MF]chondroitin sulfate bindingprobableGO:0043168, GO:1901681, GO:0097367, GO:0043167, GO:0005539, GO:0003674, GO:0005488
GO:0016597 [MF]amino acid bindingprobableGO:0043168, GO:0003674, GO:0031406, GO:0005488, GO:0043167
GO:0006210 [BP]thymine catabolic processprobableGO:0044248, GO:0072529, GO:0034641, GO:0006807, GO:0044281, GO:0046113, GO:1901360, GO:0072527, GO:0006139, GO:1901575, GO:0006208, GO:0006206, GO:0019859, GO:0071704, GO:1901361, GO:0009987, GO:0006725, GO:0044710, GO:0046700, GO:0009112, GO:0008150, GO:0008152, GO:0009056, GO:0055086, GO:0046483, GO:0044238, GO:1901564, GO:0044270, GO:0044237, GO:1901565
GO:0005739 [CC]mitochondrionprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0070382 [CC]exocytic vesicleprobableGO:0005737, GO:0043231, GO:0016023, GO:0031410, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0005575, GO:0043229, GO:0044424, GO:0030133, GO:0005622, GO:0043227, GO:0043226, GO:0031982
GO:0002058 [MF]uracil bindingprobableGO:0097159, GO:0036094, GO:0003674, GO:0005488, GO:0002054, GO:0002061, GO:1901363
GO:0051289 [BP]protein homotetramerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0051260, GO:0051262, GO:0065003, GO:0044085, GO:0008150, GO:0016043, GO:0071840
GO:0030426 [CC]growth coneprobableGO:0030427, GO:0044463, GO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0008270 [MF]zinc ion bindingprobableGO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0019482 [BP]beta-alanine metabolic processprobableGO:0044238, GO:0044710, GO:0009987, GO:1901564, GO:0006082, GO:0044237, GO:0006520, GO:0019752, GO:0071704, GO:0006807, GO:0008150, GO:0044281, GO:0008152, GO:0043436
GO:0010976 [BP]positive regulation of neuron projection developmentprobableGO:0032502, GO:0010975, GO:0030154, GO:0051128, GO:0050789, GO:0044699, GO:0031346, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0065007, GO:0048518, GO:0051130, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0008150, GO:0051239, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0044763, GO:0051960, GO:2000026, GO:0007275, GO:0048731, GO:0048522
GO:0048489 [BP]synaptic vesicle transportprobableGO:0019226, GO:0035637, GO:0051649, GO:0023052, GO:0051656, GO:0051650, GO:0044699, GO:0097480, GO:0097479, GO:0051641, GO:0032501, GO:0050877, GO:0006810, GO:0044765, GO:0008150, GO:0051648, GO:0007268, GO:0007267, GO:0007154, GO:0051234, GO:0051179, GO:0051640, GO:0003008, GO:0044700, GO:0016192, GO:0044707, GO:0044763, GO:0009987
GO:0051764 [BP]actin crosslink formationprobableGO:0006996, GO:0007015, GO:0007010, GO:0071822, GO:0030029, GO:0043933, GO:0071840, GO:0009987, GO:0030036, GO:0044763, GO:0016043, GO:0008150, GO:0044699
GO:0007411 [BP]axon guidanceprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0007265 [BP]Ras protein signal transductionprobableGO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0007264, GO:0050789, GO:0044699
GO:0014049 [BP]positive regulation of glutamate secretionprobableGO:0060341, GO:0051047, GO:0051049, GO:0023051, GO:0010646, GO:0050789, GO:0043269, GO:0044070, GO:0051046, GO:0065007, GO:0051952, GO:0051957, GO:0051954, GO:0051955, GO:0051050, GO:0050794, GO:0043270, GO:0048518, GO:0008150, GO:0032890, GO:0032892, GO:0032879, GO:0014048, GO:0048522
GO:0004157 [MF]dihydropyrimidinase activityprobableGO:0016812, GO:0016787, GO:0016810, GO:0003674, GO:0003824
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0071345 [BP]cellular response to cytokine stimulusprobableGO:0051716, GO:0034097, GO:0050896, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0001975 [BP]response to amphetamineprobableGO:0009719, GO:0050896, GO:0010243, GO:0010033, GO:0008150, GO:0042221, GO:0014075, GO:1901698
GO:0019901 [MF]protein kinase bindingprobableGO:0019900, GO:0003674, GO:0005515, GO:0019899, GO:0005488
GO:0021772 [BP]olfactory bulb developmentprobableGO:0032502, GO:0021537, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0021988, GO:0048513, GO:0030900, GO:0048731, GO:0008150, GO:0007275, GO:0044699, GO:0007417
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0005783 [CC]endoplasmic reticulumprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0021510 [BP]spinal cord developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0046135 [BP]pyrimidine nucleoside catabolic processprobableGO:0044248, GO:0072529, GO:0034641, GO:0006807, GO:0044237, GO:1901360, GO:1901361, GO:0006139, GO:1901575, GO:0071704, GO:0072527, GO:0044281, GO:0009987, GO:0006725, GO:0044710, GO:0046700, GO:0008150, GO:0009116, GO:0008152, GO:0034655, GO:0009056, GO:0055086, GO:0046483, GO:0044238, GO:1901564, GO:0044270, GO:1901136, GO:1901135, GO:0009164, GO:0006213, GO:1901657, GO:0019439, GO:1901658, GO:1901565
GO:0012505 [CC]endomembrane systemprobableGO:0005575, GO:0044464, GO:0005623
GO:0048678 [BP]response to axon injuryprobableGO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0006212 [BP]uracil catabolic processprobableGO:0044248, GO:0072529, GO:0034641, GO:0006807, GO:0044281, GO:0046113, GO:1901360, GO:0072527, GO:0006139, GO:1901575, GO:0006208, GO:0006206, GO:0071704, GO:1901361, GO:0009987, GO:0006725, GO:0044710, GO:0046700, GO:0009112, GO:0008150, GO:0008152, GO:0009056, GO:0055086, GO:0046483, GO:0044238, GO:1901564, GO:0044270, GO:0019860, GO:0044237, GO:1901565
GO:0005634 [CC]nucleusprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0005794 [CC]Golgi apparatusprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0030336 [BP]negative regulation of cell migrationprobableGO:0040013, GO:0051270, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0030334, GO:2000145, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0030425 [CC]dendriteprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0010977 [BP]negative regulation of neuron projection developmentprobableGO:0010975, GO:0030154, GO:0051129, GO:0051128, GO:0031345, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0008150, GO:0051239, GO:0048731, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0051960, GO:2000026, GO:0007275, GO:0044763, GO:0048523
GO:0051219 [MF]phosphoprotein bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0042220 [BP]response to cocaineprobableGO:1901700, GO:0009719, GO:0050896, GO:0060359, GO:0010243, GO:0010033, GO:0008150, GO:0043279, GO:0042221, GO:1901698, GO:0014070

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
3.-.-.-Hydrolases.probable
3.5.-.-Acting on carbon-nitrogen bonds, other than peptide bonds.probable
3.5.2.-In cyclic amides.probable
3.5.2.2Dihydropyrimidinase.probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 2VR2, chain A
Confidence level:very confident
Coverage over the Query: 19-514
View the alignment between query and template
View the model in PyMOL
Template: 4B90, chain A
Confidence level:very confident
Coverage over the Query: 18-512
View the alignment between query and template
View the model in PyMOL